Trios from 200 families who have lost a child to SUDC to be sequenced on PacBio’s Revio system with SPRQ-Nx chemistry, enabling increased diagnostic yield for grieving families MENLO PARK, Calif. -- PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, today announced that a UW Medicine and Seattle Children’s research effort led [...]

Multi-phase initiative will generate single cell and spatial data from over 20,000 samples across leading immuno-oncology laboratories to map the immune landscape of cancer and drive the next generation of immunotherapies and vaccine discovery PLEASANTON, Calif. -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with the Cancer [...]

The companies will work together to help pharmaceutical organizations improve efficiency and deliver better outcomes for patients. BOSTON, Mass. — TetraScience, the Scientific Data and AI company, today announced a collaboration with Thermo Fisher Scientific Inc., the world leader in serving science, with a goal of accelerating AI across biopharma R&D and manufacturing by transforming scientific [...]

Oxford Nanopore has reached a major regulatory milestone with the registration of its first In Vitro Diagnostic ("IVD") device in the UK and Europe: the GridION™ Dx. OXFORD, England -- Oxford Nanopore Technologies today announces that the GridION™ Dx is now both CE and UKCA marked, making it the company’s first IVD device registered in [...]

Additional funding of $20 million accelerates commercialization of Trailhead’s iPSC-derived human cell and media products. BEACHWOOD, Ohio and CAMBRIDGE, Mass. — Trailhead Biosystems Inc. (www.trailbio.com), a biotechnology company advancing human cell innovation, has added $20 million in new funding, expanding the financing announced in May 2025 to $40 million. The funding extension was led by [...]

Appointment strengthens leadership team as iXCells focuses on expanding its portfolio of custom-tailored iPSC products and delivery of enhanced preclinical services San Diego, CA: iXCells Biotechnologies (“iXCells”), a leading provider of human cell-based solutions and custom iPSC services, today announced the appointment of Steve Smith as CEO. Previously CCO, Steve will lead the Company to advance [...]

Alamar Biosciences, Inc. (“Alamar”), a leader in precision proteomics dedicated to advancing the early detection of disease, is proud to announce the launch of its Research Use Only (RUO) NULISAqpcr™ AD 5-plex Assay. This innovative solution enables simultaneous quantitative measurement of five critical blood-based biomarkers relevant to the Alzheimer’s Association recommended guidelines: brain-derived phosphorylated tau [...]

T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors Fremont, Calif. –  Alamar Biosciences, Inc. (“Alamar”), a leader in precision proteomics dedicated to advancing the early detection of disease, announced the close of an oversubscribed [...]

Genialis Expressions empowers drug development teams to make confident decisions by unifying workflows and standardizing omics data for enterprise-grade clarity and comparability across studies BOSTON & LAUSANNE, Switzerland -- Genialis, the RNA biomarker company, today announced that Swiss-based biopharmaceutical company Debiopharm has deployed the Genialis™ Expressions software platform within its cloud infrastructure to support biomarker discovery and [...]

London – M&G Investments (M&G) today announces that it is leading a US$50 million Series C funding round for bit.bio, the Cambridge-based biotech company pioneering next-generation human cell programming technology. The investment of patient capital into a fast-growing private UK company, spun out from the University of Cambridge, marks a major vote of confidence in [...]